Brainsway Ltd.

5.50+0.0600+1.10%Vol 2.00K1Y Perf -32.76%
Aug 12th, 2022 15:03 DELAYED
BID5.50 ASK5.61
Open5.48 Previous Close5.44
Pre-Market- After-Market5.44
 - -  -0.06 -1.09%
Target Price
14.17 
Analyst Rating
Strong Buy 1.17
Potential %
157.64 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★+     60.08
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★+     54.24
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
19.01 
Earnings Rating
Strong Buy
Market Cap90.75M 
Earnings Date
10th Aug 2022
Alpha-0.02 Standard Deviation0.14
Beta1.27 

Today's Price Range

5.460.00

52W Range

4.3510.40

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-11.43%
1 Month
-3.00%
3 Months
0.92%
6 Months
-27.73%
1 Year
-32.76%
3 Years
-40.86%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BWAY5.500.06001.10
AAPL172.123.63002.15
GOOG122.652.83002.36
MSFT291.914.89001.70
XOM94.000.81000.87
WFC45.940.69001.52
JNJ165.30-1.8400-1.10
FB196.640.99000.51
GE79.931.03001.31
JPM122.131.99001.66
 
ProfitabilityValueIndustryS&P 500US Markets
77.80
-22.30
-17.20
-35.90
-21.00
RevenueValueIndustryS&P 500US Markets
24.50M
1.48
-
-
Earnings HistoryEstimateReportedSurprise %
Q02 2022-0.08-0.0712.50
Q01 2022-0.09-0.0633.33
Q04 2021-0.06-0.0433.33
Q03 2021-0.06-0.0516.67
Q02 2021-0.07-0.0614.29
Q01 2021-0.08-0.11-37.50
Q04 2020-0.05-0.0260.00
Q03 2020-0.06-0.0433.33
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.0811.11Positive
9/2022 QR-0.0614.29Positive
12/2022 FY-0.2414.29Positive
12/2023 FY-0.2013.04Positive
Next Report Date-
Estimated EPS Next Report-0.08
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume2.00K
Shares Outstanding16.50K
Shares Float16.50M
Trades Count50
Dollar Volume10.88K
Avg. Volume18.15K
Avg. Weekly Volume24.76K
Avg. Monthly Volume12.68K
Avg. Quarterly Volume17.00K

Brainsway Ltd. (NASDAQ: BWAY) stock closed at 5.5 per share at the end of the most recent trading day (a 1.1% change compared to the prior day closing price) with a volume of 2.00K shares and market capitalization of 90.75M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 107 people. Brainsway Ltd. CEO is Christopher Richard von Jako.

The one-year performance of Brainsway Ltd. stock is -32.76%, while year-to-date (YTD) performance is -28.57%. BWAY stock has a five-year performance of %. Its 52-week range is between 4.35 and 10.4, which gives BWAY stock a 52-week price range ratio of 19.01%

Brainsway Ltd. currently has a PE ratio of -13.00, a price-to-book (PB) ratio of 1.61, a price-to-sale (PS) ratio of 3.66, a price to cashflow ratio of 96.00, a PEG ratio of 2.32, a ROA of -9.49%, a ROC of -12.13% and a ROE of -12.10%. The company’s profit margin is -21.00%, its EBITDA margin is -17.20%, and its revenue ttm is $24.50 Million , which makes it $1.48 revenue per share.

Of the last four earnings reports from Brainsway Ltd., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.08 for the next earnings report. Brainsway Ltd.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Brainsway Ltd. is Strong Buy (1.17), with a target price of $14.17, which is +157.64% compared to the current price. The earnings rating for Brainsway Ltd. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Brainsway Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Brainsway Ltd. has a Sell technical analysis rating based on Technical Indicators (ADX : 16.96, ATR14 : 0.36, CCI20 : -177.09, Chaikin Money Flow : -0.35, MACD : 0.07, Money Flow Index : 41.51, ROC : -8.64, RSI : 43.15, STOCH (14,3) : 9.09, STOCH RSI : 0.04, UO : 47.42, Williams %R : -90.91), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Brainsway Ltd. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (83.33 %)
5 (83.33 %)
5 (83.33 %)
Moderate Buy
1 (16.67 %)
1 (16.67 %)
1 (16.67 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.17
Strong Buy
1.17
Strong Buy
1.17

Brainsway Ltd.

Brainsway Ltd is an Israel based company engaged in the business of developing and providing advanced technology solutions for the treatment of a variety of brain disorders. Its flagship technology is based on Deep Transcranial Magnetic Stimulation (TMS) which is used for brain disorder treatment such as treatment of depression in patients. The group earns revenues from the sale and lease of devices. It has a business presence in Israel and other foreign countries.

CEO: Christopher Richard von Jako

Telephone: +972 25813140

Address: 19 Hartum Street, Jerusalem 9777518, , IL

Number of employees: 107

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

71%29%

Bearish Bullish

73%27%


News

Stocktwits